Therapy News and Research

RSS

Theraclion unveils very positive initial clinical results in treatment of thyroid nodules

Theraclion, a company specializing in advanced medical equipment for echotherapy (or ultrasound therapy), has unveiled very positive initial clinical results in the treatment of thyroid nodules. These findings demonstrate the effectiveness of its Echopulse device in the treatment of this condition.

10 Oct 2013

Possible topical treatment for age-related macular degeneration identified by Tufts researchers

Researchers from Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences have identified a possible topical treatment for age-related macular degeneration in a study of mice that shows promise for clinical use.

10 Oct 2013

Hypertension affects over 40% of Chinese adults, shows WHO report

With a recent World Health Organization report showing hypertension affects over 40% of Chinese adults aged 45 or older, combating high blood pressure will be high on the agenda of the 24th Great Wall International Congress of Cardiology & Asia Pacific Heart Congress, in Beijing (10 to 13 October 2013).

10 Oct 2013

CAC receives $1M grant to render services to young sexual assault victims

The Orange County Children's Advocacy Center (CAC) has been awarded a grant of nearly $1 million to help close gaps in existing services to young sexual assault victims.

10 Oct 2013

Receiving care at several HIV clinics may increase medication errors

Patients who received care at multiple HIV clinics-as opposed to only one- were less likely to take their medication and had higher HIV viral loads, a new study published in the journal AIDS and Behavior of almost 13,000 HIV patients in Philadelphia from Penn Medicine found.

10 Oct 2013

Key findings may have broad implications for future scleroderma therapy

The Scleroderma Research Foundation today said that researchers at The Johns Hopkins University working in a novel mouse model of Stiff Skin Syndrome have made key discoveries that may have broad implications for future scleroderma therapy.

10 Oct 2013

Allegro receives FDA IND approval to initiate Phase II clinical studies of ALG-1001 in AMD, VMT patients

Allegro Ophthalmics, LLC, a company dedicated to establishing Integrin Peptide Therapy as the next-generation pharmaceutical category for the treatment of vascular eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to begin two Phase II clinical studies of ALG-1001.

10 Oct 2013

Dry eye disease symptom change independent of tear osmolarity

Tear osmolarity is a poor indicator of treatment response in patients with dry eye disease (DED), suggests research published in the American Journal of Ophthalmology.

9 Oct 2013

HIV infection heralds worse outcomes in NSCLC

Infection with HIV is an indicator of poor prognosis in patients with non-small-cell lung cancer, analysis of epidemiologic data indicates.

9 Oct 2013

Asthma infection risk ‘goes beyond the airways’

Researchers from the USA have found that asthma may be associated with an increased risk for infections outside of the respiratory tract.

9 Oct 2013

Catalyst, Isu Abxis To Develop Hemophilia B Candidate

...

9 Oct 2013

Compugen drug candidate prevents autoimmune type I diabetes in animal model

Compugen Ltd., announced today that CGEN-15001, an Fc fusion protein drug candidate derived from a novel immune checkpoint protein discovered by Compugen, has been shown to be highly efficient in preventing the development of disease in a well-accepted animal model of autoimmune type I diabetes, known also as juvenile diabetes.

9 Oct 2013

ARIAD announces changes in Iclusig product labeling to reflect updated safety information

ARIAD Pharmaceuticals, Inc. today announced results of its review of updated clinical data from the pivotal PACE trial of Iclusig® (ponatinib) and actions that it is taking following consultations with the U.S. Food and Drug Administration (FDA).

9 Oct 2013

Molecular Templates secures $8.5M series C financing plus $10.6M grant from CPRIT

Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of biologic therapeutics, announced today that it recently secured an $8.5M series C financing led by Excel Venture Management. Santé Ventures, an existing investor, also participated in the round.

9 Oct 2013

Oncosec Medical reports encouraging results from combination study on aggressive melanoma

OncoSec Medical Inc., a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumors, has announced positive preliminary animal data demonstrating the benefits of combining the company's ImmunoPulse with anti-CTLA4 and anti-PD1 antibodies.

9 Oct 2013

Widespread prescription of levothyroxine medication may cause more harm than good

A study of patients in the United Kingdom suggests widespread prescribing of the medication levothyroxine sodium to boost thyroid function among patients with borderline high levels of the thyroid-stimulating hormone thyrotropin (a sign of low thyroid function), raising the possibility of overtreatment, according to a study published by JAMA Internal Medicine, a JAMA Network publication.

9 Oct 2013

New combinations of postoperative pain treatment decreased both pain and use of pain relievers

New combinations of postoperative pain treatment decreased both pain and the use of narcotic pain relievers according to two studies presented this week at the 2013 Clinical Congress of the American College of Surgeons.

9 Oct 2013

Studies suggest infusion of blood vessel cells may contribute to organ regeneration in future

Damaged or diseased organs may someday be healed with an injection of blood vessel cells, eliminating the need for donated organs and transplants, according to scientists at Weill Cornell Medical College.

9 Oct 2013

Three Penn Medicine researchers awarded grants for neuromuscular disease research

The Muscular Dystrophy Association has awarded research grants totaling over $1,000,000 to three Penn Medicine researchers: James Shorter, PhD, associate professor of Biochemistry and Biophysics; Hansell Stedman, MD, associate professor of Surgery; and Lee Sweeney, PhD, director of the Center for Orphan Disease Research and Therapy.

9 Oct 2013

Gemcitabine drug improves survival rates in patients with pancreatic cancer

Among patients with pancreatic cancer who had surgery for removal of the cancer, treatment with the drug gemcitabine for 6 months resulted in increased overall survival as well as disease-free survival, compared with observation alone, according to a study in the October 9 issue of JAMA.

9 Oct 2013

Therapy News and Research

Theraclion unveils very positive initial clinical results in treatment of thyroid nodules

Possible topical treatment for age-related macular degeneration identified by Tufts researchers

Hypertension affects over 40% of Chinese adults, shows WHO report

CAC receives $1M grant to render services to young sexual assault victims

Receiving care at several HIV clinics may increase medication errors

Key findings may have broad implications for future scleroderma therapy

Allegro receives FDA IND approval to initiate Phase II clinical studies of ALG-1001 in AMD, VMT patients

Dry eye disease symptom change independent of tear osmolarity

HIV infection heralds worse outcomes in NSCLC

Asthma infection risk ‘goes beyond the airways’

Catalyst, Isu Abxis To Develop Hemophilia B Candidate

Compugen drug candidate prevents autoimmune type I diabetes in animal model

ARIAD announces changes in Iclusig product labeling to reflect updated safety information

Molecular Templates secures $8.5M series C financing plus $10.6M grant from CPRIT

Oncosec Medical reports encouraging results from combination study on aggressive melanoma

Widespread prescription of levothyroxine medication may cause more harm than good

New combinations of postoperative pain treatment decreased both pain and use of pain relievers

Studies suggest infusion of blood vessel cells may contribute to organ regeneration in future

Three Penn Medicine researchers awarded grants for neuromuscular disease research

Gemcitabine drug improves survival rates in patients with pancreatic cancer

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News